A Form 4 filed on November 12, 2026 with the U.S. Securities and Exchange Commission reports that Ferroglobe PLC director Bruce Larmour Crockett purchased 8,000 ordinary shares on November 6, 2026 at a price of $2.669 per share.
GP-Act III Acquisition Corp. filed a current report on November 12, 2026, disclosing Non-Redemption Agreements entered into on November 10, 2026, covering 2,525,000 Class A ordinary shares ahead of an extraordinary general meeting scheduled for the same day as the filing.
A Form 4 filed on November 12, 2026 with the SEC disclosed that Peng Alex Zhuangzhuang, President and Chief Financial Officer of TAL Education Group (NYSE:TAL), exercised stock options and had shares withheld for taxes on November 9, 2026.
David Marie Gabriel Girardeau, Chief People and Culture Officer of Ferroglobe PLC, filed a Form 4 on November 12, 2026, reporting the open-market purchase of 15,500 ordinary shares on November 6, 2026.
KDT Ibotta Holdings, LLC, a 10% owner of Ibotta, Inc. (NASDAQ:IBTA), filed a Form 4 on November 12, 2026, disclosing the sale of 200,000 shares of Class A Common Stock across two transactions on November 9 and November 10, 2026.
Banco Santander, S.A. filed a Form 6-K on November 12, 2026, reporting the November 11, 2026 registration of a capital reduction deed involving the cancellation of 150,595,100 own shares, reducing share capital by EUR 75,297,550.
Banco Santander, S.A. filed a Form 6-K with the SEC on November 12, 2026, announcing a 5% increase in the exchange ratio for its intended voluntary exchange offer to acquire the outstanding minority shares of Santander Brasil.
Banco Santander, S.A. filed a Form 425 on November 12, 2026, announcing a 5% increase in the exchange ratio for its intended voluntary exchange offer to acquire all outstanding minority shares of Banco Santander (Brasil) S.A. not already owned by Santander.
Amir F. Heshmatpour, CEO, President, and Director of NeOnc Technologies Holdings, Inc., filed a Form 4 on November 12, 2026, reporting the open-market purchase of 70,000 shares of common stock across three transactions on November 10 and November 11, 2026.
Thomas C. Chen, a director, 10% owner, and Chief Medical Officer of NeoNC Technologies Holdings, Inc., filed a Form 4 on November 12, 2026, reporting two open-market purchases of common stock on November 9 and November 10, 2026.